Serveur d'exploration sur les interactions arbre microorganisme

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Host defense impairments that may lead to respiratory infections.

Identifieur interne : 000295 ( Main/Exploration ); précédent : 000294

Host defense impairments that may lead to respiratory infections.

Auteurs : H Y Reynolds [États-Unis]

Source :

RBID : pubmed:3311580

Descripteurs français

English descriptors

Abstract

Host defense mechanisms spaced along the respiratory tree and in the alveolar spaces effectively remove or contend with micro-organisms that enter the airways, so serious lung infections occur rarely in healthy people. Special circumstances, such as virgin exposure to a virulent microbe or a large innoculum of a pathogen, can result in illness, but usually routine surveillance host defenses are protective and suffice to keep colonizing airway flora in check. When pneumonia develops or recurrent sinopulmonary infection exists, however, some element of the normal defense apparatus may have failed or is inadequate. This review highlights several components of the apparatus, that is immunoglobulins IgG and IgA and the interaction of alveolar macrophages and lymphocytes, and examines deficiencies in their function that may result in infection. Along the conducting airways, poor mucociliary clearance and/or deficiencies in certain IgG subclass antibodies or destruction of IgA may predispose to sinopulmonary infections; these may be a manifestation of a hereditary disease. In pneumonia the alveolar macrophage is positioned as the central cell which must respond in several directions. This scavenger phagocyte first intercepts the microbe and either can kill or contain it or must call in some other phagocytic cell or inflammatory mediator(s) for assistance. Opsonic antibodies (IgG) and other nonimmune opsonins (complement and surfactant or fibronectin fragments) facilitate phagocytosis, but an absence of antibody may permit infection to develop with encapsulated bacteria (pneumococcus). Insufficient bone marrow reserves of PMNs or a paucity of chemotactic factors to attract them into the alveoli is a situation that may permit gram-negative bacilli and fungal organisms to flourish. Inability of immune T-lymphocytes to energize macrophages, through soluble cellular mediators that provide cell-mediated immunity and activation, makes containment of certain intracellular microbes impossible for these phagocytes (Legionella or mycobacteria). Likewise, concomitant infection of macrophages with viruses (human immunodeficiency virus, and cytomegalovirus or herpes viruses) plus an excessive T-lymphocyte suppressor cell influence may make P. carinii and common bacterial and fungal organisms difficult to contain in the lungs of AIDS patients. Consideration about what the lung host deficiency might be can make therapy more specific through immunization to develop special antibodies, replacement of certain immunoglobulins (IgG subclasses), or selective administration of cell mediators (gamma-interferon or interleukins).

PubMed: 3311580


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Host defense impairments that may lead to respiratory infections.</title>
<author>
<name sortKey="Reynolds, H Y" sort="Reynolds, H Y" uniqKey="Reynolds H" first="H Y" last="Reynolds">H Y Reynolds</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pulmonary Section, Yale University School of Medicine, New Haven, Connecticut.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Connecticut</region>
</placeName>
<wicri:cityArea>Pulmonary Section, Yale University School of Medicine, New Haven</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1987">1987</date>
<idno type="RBID">pubmed:3311580</idno>
<idno type="pmid">3311580</idno>
<idno type="wicri:Area/Main/Corpus">000295</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000295</idno>
<idno type="wicri:Area/Main/Curation">000295</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000295</idno>
<idno type="wicri:Area/Main/Exploration">000295</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Host defense impairments that may lead to respiratory infections.</title>
<author>
<name sortKey="Reynolds, H Y" sort="Reynolds, H Y" uniqKey="Reynolds H" first="H Y" last="Reynolds">H Y Reynolds</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pulmonary Section, Yale University School of Medicine, New Haven, Connecticut.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Connecticut</region>
</placeName>
<wicri:cityArea>Pulmonary Section, Yale University School of Medicine, New Haven</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Clinics in chest medicine</title>
<idno type="ISSN">0272-5231</idno>
<imprint>
<date when="1987" type="published">1987</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antibody Formation (MeSH)</term>
<term>Bronchoalveolar Lavage Fluid (cytology)</term>
<term>Bronchoalveolar Lavage Fluid (immunology)</term>
<term>Humans (MeSH)</term>
<term>Immunity, Cellular (MeSH)</term>
<term>Immunoglobulins (analysis)</term>
<term>Immunologic Deficiency Syndromes (complications)</term>
<term>Nasal Mucosa (metabolism)</term>
<term>Respiratory Tract Infections (etiology)</term>
<term>Respiratory Tract Infections (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Déficits immunitaires (complications)</term>
<term>Humains (MeSH)</term>
<term>Immunité cellulaire (MeSH)</term>
<term>Immunoglobulines (analyse)</term>
<term>Infections de l'appareil respiratoire (immunologie)</term>
<term>Infections de l'appareil respiratoire (étiologie)</term>
<term>Liquide de lavage bronchoalvéolaire (cytologie)</term>
<term>Liquide de lavage bronchoalvéolaire (immunologie)</term>
<term>Muqueuse nasale (métabolisme)</term>
<term>Production d'anticorps (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Immunoglobulins</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Immunoglobulines</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Immunologic Deficiency Syndromes</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Liquide de lavage bronchoalvéolaire</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Bronchoalveolar Lavage Fluid</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Infections de l'appareil respiratoire</term>
<term>Liquide de lavage bronchoalvéolaire</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Bronchoalveolar Lavage Fluid</term>
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Nasal Mucosa</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Muqueuse nasale</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Infections de l'appareil respiratoire</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Antibody Formation</term>
<term>Humans</term>
<term>Immunity, Cellular</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="fr">
<term>Déficits immunitaires</term>
<term>Humains</term>
<term>Immunité cellulaire</term>
<term>Production d'anticorps</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Host defense mechanisms spaced along the respiratory tree and in the alveolar spaces effectively remove or contend with micro-organisms that enter the airways, so serious lung infections occur rarely in healthy people. Special circumstances, such as virgin exposure to a virulent microbe or a large innoculum of a pathogen, can result in illness, but usually routine surveillance host defenses are protective and suffice to keep colonizing airway flora in check. When pneumonia develops or recurrent sinopulmonary infection exists, however, some element of the normal defense apparatus may have failed or is inadequate. This review highlights several components of the apparatus, that is immunoglobulins IgG and IgA and the interaction of alveolar macrophages and lymphocytes, and examines deficiencies in their function that may result in infection. Along the conducting airways, poor mucociliary clearance and/or deficiencies in certain IgG subclass antibodies or destruction of IgA may predispose to sinopulmonary infections; these may be a manifestation of a hereditary disease. In pneumonia the alveolar macrophage is positioned as the central cell which must respond in several directions. This scavenger phagocyte first intercepts the microbe and either can kill or contain it or must call in some other phagocytic cell or inflammatory mediator(s) for assistance. Opsonic antibodies (IgG) and other nonimmune opsonins (complement and surfactant or fibronectin fragments) facilitate phagocytosis, but an absence of antibody may permit infection to develop with encapsulated bacteria (pneumococcus). Insufficient bone marrow reserves of PMNs or a paucity of chemotactic factors to attract them into the alveoli is a situation that may permit gram-negative bacilli and fungal organisms to flourish. Inability of immune T-lymphocytes to energize macrophages, through soluble cellular mediators that provide cell-mediated immunity and activation, makes containment of certain intracellular microbes impossible for these phagocytes (Legionella or mycobacteria). Likewise, concomitant infection of macrophages with viruses (human immunodeficiency virus, and cytomegalovirus or herpes viruses) plus an excessive T-lymphocyte suppressor cell influence may make P. carinii and common bacterial and fungal organisms difficult to contain in the lungs of AIDS patients. Consideration about what the lung host deficiency might be can make therapy more specific through immunization to develop special antibodies, replacement of certain immunoglobulins (IgG subclasses), or selective administration of cell mediators (gamma-interferon or interleukins).</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">3311580</PMID>
<DateCompleted>
<Year>1987</Year>
<Month>12</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>30</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0272-5231</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>8</Volume>
<Issue>3</Issue>
<PubDate>
<Year>1987</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Clinics in chest medicine</Title>
<ISOAbbreviation>Clin Chest Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Host defense impairments that may lead to respiratory infections.</ArticleTitle>
<Pagination>
<MedlinePgn>339-58</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Host defense mechanisms spaced along the respiratory tree and in the alveolar spaces effectively remove or contend with micro-organisms that enter the airways, so serious lung infections occur rarely in healthy people. Special circumstances, such as virgin exposure to a virulent microbe or a large innoculum of a pathogen, can result in illness, but usually routine surveillance host defenses are protective and suffice to keep colonizing airway flora in check. When pneumonia develops or recurrent sinopulmonary infection exists, however, some element of the normal defense apparatus may have failed or is inadequate. This review highlights several components of the apparatus, that is immunoglobulins IgG and IgA and the interaction of alveolar macrophages and lymphocytes, and examines deficiencies in their function that may result in infection. Along the conducting airways, poor mucociliary clearance and/or deficiencies in certain IgG subclass antibodies or destruction of IgA may predispose to sinopulmonary infections; these may be a manifestation of a hereditary disease. In pneumonia the alveolar macrophage is positioned as the central cell which must respond in several directions. This scavenger phagocyte first intercepts the microbe and either can kill or contain it or must call in some other phagocytic cell or inflammatory mediator(s) for assistance. Opsonic antibodies (IgG) and other nonimmune opsonins (complement and surfactant or fibronectin fragments) facilitate phagocytosis, but an absence of antibody may permit infection to develop with encapsulated bacteria (pneumococcus). Insufficient bone marrow reserves of PMNs or a paucity of chemotactic factors to attract them into the alveoli is a situation that may permit gram-negative bacilli and fungal organisms to flourish. Inability of immune T-lymphocytes to energize macrophages, through soluble cellular mediators that provide cell-mediated immunity and activation, makes containment of certain intracellular microbes impossible for these phagocytes (Legionella or mycobacteria). Likewise, concomitant infection of macrophages with viruses (human immunodeficiency virus, and cytomegalovirus or herpes viruses) plus an excessive T-lymphocyte suppressor cell influence may make P. carinii and common bacterial and fungal organisms difficult to contain in the lungs of AIDS patients. Consideration about what the lung host deficiency might be can make therapy more specific through immunization to develop special antibodies, replacement of certain immunoglobulins (IgG subclasses), or selective administration of cell mediators (gamma-interferon or interleukins).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Reynolds</LastName>
<ForeName>H Y</ForeName>
<Initials>HY</Initials>
<AffiliationInfo>
<Affiliation>Pulmonary Section, Yale University School of Medicine, New Haven, Connecticut.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Clin Chest Med</MedlineTA>
<NlmUniqueID>7907612</NlmUniqueID>
<ISSNLinking>0272-5231</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007136">Immunoglobulins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CitationSubset>X</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000917" MajorTopicYN="N">Antibody Formation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001992" MajorTopicYN="N">Bronchoalveolar Lavage Fluid</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007111" MajorTopicYN="N">Immunity, Cellular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007136" MajorTopicYN="N">Immunoglobulins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007153" MajorTopicYN="N">Immunologic Deficiency Syndromes</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009297" MajorTopicYN="N">Nasal Mucosa</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>107</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1987</Year>
<Month>9</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1987</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1987</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">3311580</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Connecticut</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Connecticut">
<name sortKey="Reynolds, H Y" sort="Reynolds, H Y" uniqKey="Reynolds H" first="H Y" last="Reynolds">H Y Reynolds</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/TreeMicInterV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000295 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000295 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    TreeMicInterV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:3311580
   |texte=   Host defense impairments that may lead to respiratory infections.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:3311580" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a TreeMicInterV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Thu Nov 19 16:52:21 2020. Site generation: Thu Nov 19 16:52:50 2020